MOORE DAVID SCOTT purchased 21.70K shares of CORVUS PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $250.2K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 6/15/2026ACC: 0001610717-26-000223
Director
Since Oct 2025
+36.70K
Net shares
Net buyer
$250.2K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
36.70K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+21.70K
Price / share
$11.53
Trade value
$250.24K
% of position
New position
6/11/2026
0.00→21.70K
Total
Net shares
+21.70K
Net value
$250.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | P · Purchase | +21.70K | $11.53 | $250.24K | New position | 0.00 | 21.70K |
| Total | +21.70K | $250.24K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15K shares
Shares
+15K
Strike price
11.6
Held after
15K
Exercisable
—
6/11/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15K shares | 6/11/2026 | A · Award | +15K | 11.6 | — | 15K |